242 related articles for article (PubMed ID: 35008269)
1. Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia.
Böhme M; Kayser S
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008269
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
[TBL] [Abstract][Full Text] [Related]
3. Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.
Assi R; Kantarjian H; Ravandi F; Daver N
Curr Opin Hematol; 2018 Mar; 25(2):136-145. PubMed ID: 29206680
[TBL] [Abstract][Full Text] [Related]
4. Emerging Immunotherapy for Acute Myeloid Leukemia.
Tabata R; Chi S; Yuda J; Minami Y
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669431
[TBL] [Abstract][Full Text] [Related]
5. Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical Practice.
Masarova L; Kantarjian H; Ravandi F; Sharma P; Garcia-Manero G; Daver N
Adv Exp Med Biol; 2018; 995():97-116. PubMed ID: 30539507
[TBL] [Abstract][Full Text] [Related]
6. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments.
Daver N; Alotaibi AS; Bücklein V; Subklewe M
Leukemia; 2021 Jul; 35(7):1843-1863. PubMed ID: 33953290
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Advances in Immunotherapies for Hematological Malignancies.
Nogami A; Sasaki K
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232824
[TBL] [Abstract][Full Text] [Related]
8. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia.
Restelli C; Ruella M; Paruzzo L; Tarella C; Pelicci PG; Colombo E
Blood Cancer Discov; 2024 Jun; ():OF1-OF15. PubMed ID: 38904305
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?
Spillane DR; Assouline S
Expert Rev Hematol; 2023; 16(11):819-834. PubMed ID: 37819154
[TBL] [Abstract][Full Text] [Related]
11. Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia.
Brunner AM
Curr Opin Hematol; 2023 Mar; 30(2):38-44. PubMed ID: 36728945
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia.
Haddad F; Zeidan AM; Daver N
Cancer J; 2022 Jan-Feb 01; 28(1):43-50. PubMed ID: 35072373
[TBL] [Abstract][Full Text] [Related]
13. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
14. Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.
Guy DG; Uy GL
Curr Hematol Malig Rep; 2018 Dec; 13(6):417-425. PubMed ID: 30280288
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Acute Myeloid Leukemia: Where We Stand.
Isidori A; Cerchione C; Daver N; DiNardo C; Garcia-Manero G; Konopleva M; Jabbour E; Ravandi F; Kadia T; Burguera AF; Romano A; Loscocco F; Visani G; Martinelli G; Kantarjian H; Curti A
Front Oncol; 2021; 11():656218. PubMed ID: 34041025
[TBL] [Abstract][Full Text] [Related]
16. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
Stanchina M; Soong D; Zheng-Lin B; Watts JM; Taylor J
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33139625
[TBL] [Abstract][Full Text] [Related]
17. The Role of T Cell Immunotherapy in Acute Myeloid Leukemia.
Hao F; Sholy C; Wang C; Cao M; Kang X
Cells; 2021 Dec; 10(12):. PubMed ID: 34943884
[TBL] [Abstract][Full Text] [Related]
18. Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations.
Patel SA; Bello E; Wilks A; Gerber JM; Sadagopan N; Cerny J
Leuk Res; 2023 Nov; 134():107388. PubMed ID: 37729719
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in immunotherapy of acute myeloid leukemia.
Lichtenegger FS; Krupka C; Haubner S; Köhnke T; Subklewe M
J Hematol Oncol; 2017 Jul; 10(1):142. PubMed ID: 28743264
[TBL] [Abstract][Full Text] [Related]
20. An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid Leukemia.
Venugopal S; Daver N; Ravandi F
Curr Hematol Malig Rep; 2021 Feb; 16(1):89-96. PubMed ID: 33630233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]